Stockpile Inventory Modernization Act of 2020
This bill authorizes the Department of Health and Human Services (HHS) to transfer certain supplies from the Strategic National Stockpile to any federal department or agency on a reimbursable basis, provided that (1) the supplies are less than six months from their expiration date, (2) the stockpile is able to replenish them, and (3) the transfer is in the best interest of the government.
HHS shall submit a report to Congress that includes each transfer and the amount reimbursed for the supplies. The authority to make such transfers terminates on September 20, 2023.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6517 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 6517
To amend the Public Health Service Act to authorize the transfer to any
Federal department or agency, on a reimbursable basis, any drugs,
vaccines and other biological products, medical devices, and other
supplies in the Strategic National Stockpile, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 17, 2020
Mrs. Brooks of Indiana (for herself and Ms. Eshoo) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to authorize the transfer to any
Federal department or agency, on a reimbursable basis, any drugs,
vaccines and other biological products, medical devices, and other
supplies in the Strategic National Stockpile, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Stockpile Inventory Modernization
Act of 2020''.
SEC. 2. REIMBURSABLE TRANSFERS FROM STRATEGIC NATIONAL STOCKPILE.
Section 319F-2(a) of the Public Health Service Act (42 U.S.C. 247d-
6b(a)) is amended by adding at the end the following:
``(6) Transfers and reimbursements.--
``(A) In general.--Without regard to chapter 5 of
title 40, United States Code, the Secretary may
transfer to any Federal department or agency, on a
reimbursable basis, any drugs, vaccines and other
biological products, medical devices, and other
supplies in the stockpile if--
``(i) the transferred supplies are less
than six months from expiry;
``(ii) the stockpile is able to replenish
the supplies, as appropriate; and
``(iii) the Secretary decides the transfer
is in the best interest of the United States
Government.
``(B) Use of reimbursement.--Reimbursement derived
from the transfer of supplies pursuant to subparagraph
(A) may be used by the Secretary, without further
appropriation and without fiscal year limitation, to
carry out this section.
``(C) Report.--Not later than September 30, 2022,
the Secretary shall submit to the Committee on Energy
and Commerce of the House of Representatives and the
Committee on Health, Education, Labor, and Pensions of
the Senate a report on each transfer made under this
paragraph and the amount received by the Secretary in
exchange for that transfer.
``(D) Sunset.--The authority to make transfers
under this paragraph shall cease to be effective on
September 30, 2023.''.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line